Vivo Surgical

What Vivo Surgical does

Vivo Surgical Private Limited is a Singapore-based medical device developer and manufacturer founded in 2018 by Dr. Kevin Koh, focused on three proprietary surgical technology platforms: in vivo surgical lighting (KLARO™), portable flexible endoscopy (ENLYT®), and minimally-invasive endoscopic surgical robotics (ERES™). KLARO, the company's flagship and only commercially approved product, is a sterile, single-use, bendable LED light strip (4.6mm diameter, 340° illumination) that illuminates deep surgical cavities from within, addressing limitations of overhead surgical lights and headlamps; it received FDA 510(k) clearance, CE Mark certification, and Singapore HSA approval in 2020, and is distributed through 17+ partners across Southeast Asia, MENA, China, the US, and Europe. ENLYT is a portable flexible endoscope system for screening and imaging applications (notably nasopharyngoscopy), currently in development with clinical validation published in Surgical Innovation in August 2025 showing non-inferiority to standard-of-care across 50 patients. ERES is a minimally-invasive endoscopic surgical robotic system that integrates with existing conventional endoscopes, positioned for advanced endoluminal and NOTES-based procedures, with Singapore General Hospital designated as a Centre of Excellence under a December 2025 MOU.

The company operates an asset-light commercial model: revenue (where generated) comes from quote-based, enterprise-grade hardware sales of KLARO and accessories to hospitals and academic medical centers, supplemented by professional services for training and implementation, with distribution executed primarily through a 17+ partner global channel network and direct enterprise sales in the US and Europe. Customers to date are concentrated among Singapore public healthcare institutions — Singapore General Hospital, SingHealth, National Cancer Centre Singapore, and National Dental Centre Singapore — alongside research partnerships with Duke University, Mount Sinai Innovation Partners, NIH, and Johnson & Johnson Innovation JLABS (Singapore). Manufacturing is anchored by a wholly-owned subsidiary, Vivo Surgical (Suzhou) Co., Ltd, established January 2023 in the China-Singapore Suzhou Industrial Park to serve the China market.

Vivo Surgical has not disclosed external venture or growth funding, operates with a headcount of 1-10 employees, and has not publicly disclosed revenue. The company has been recognized by the World Intellectual Property Organization with the WIPO-IPOS IP for Innovation Award (2022) and the WIPO Global Awards (2024), and was a Top 4 Grand Prize Finalist in the MedTech Innovator Asia Pacific 2023 competition. Its strategic posture is that of a founder-led, IP-driven medical device company transitioning from a single approved product (KLARO) toward a multi-product platform spanning lighting, endoscopy, and surgical robotics, with international clinical and business advisory boards assembled to support commercial scale-up.

Name

Vivo Surgical

Legal name

Vivo Surgical Private Limited

Website

https://vivo-surgical.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Vivo Surgical is a Singapore-based medical device company developing in vivo surgical lighting (KLARO™), portable flexible endoscopy (ENLYT®), and minimally-invasive endoscopic surgical robotics (ERES™) for hospitals, academic medical centers, and integrated health systems across Asia, the US, and Europe.

Ownership category

akta.pro rank

Product category

Surgical Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Surgical medical devices
• In vivo surgical lighting
• Portable flexible endoscopy
• Endoscopic surgical robotics
• Minimally invasive surgery

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Others

Revenue model

1. Medical Device Hardware Sales: Primary revenue stream from sale of surgical lighting devices (KLARO™), flexible endoscopes (ENLYT®), and endoscopic surgical robots (ERES™). Revenue is generated through one-time hardware sales to hospitals and healthcare providers, with potential for follow-on sales of accessories and consumables.
2. Professional Services: Training, implementation, and support services related to the deployment and use of surgical devices. Services provided to hospital systems adopting the technology.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Vivo Surgical develops and manufactures proprietary medical devices for minimally invasive surgery, including KLARO™, a sterile single-use in vivo surgical LED lighting device; ENLYT®, a portable flexible endoscope system for screening and imaging; and ERES™, a minimally-invasive endoscopic surgical robotic system. The company sells these devices primarily to hospitals, academic medical centers, and healthcare systems globally through a combination of distributors and direct enterprise sales.

Product overview

Vivo Surgical is a medical technology developer and manufacturer offering a portfolio of surgical devices spanning in vivo lighting, portable endoscopy, and endoscopic robotics. KLARO™ is the CE-certified and FDA-cleared flagship in vivo surgical lighting product—a sterile, single-use, bendable LED light strip that illuminates surgical cavities from within, addressing inadequate illumination in deep and narrow surgical sites. ENLYT® is a portable flexible endoscope system for screening and imaging applications, currently under development with clinical validation completed. ERES™ is a minimally-invasive endoscopic surgical robotic system designed to integrate with existing conventional endoscopes. These products target unmet clinical needs in hospitals and beyond, with KLARO already distributed internationally, ENLYT in clinical validation stage, and ERES in development with clinical deployment partnerships established.

Differentiator

Problem solved

Functional benefit

Brands

• KLARO: In vivo surgical lighting device - a sterile, single-use flexible LED light strip that illuminates surgical cavities from the inside, providing wide-angle illumination for deep and narrow surgical cavities
• ENLYT
• ERES

Products and services

• KLARO™ KLARO™ is a sterile, single-use, bendable in vivo surgical LED lighting device (4.6mm diameter, 340° illumination, four light intensity levels, safe operating temperature below 38°C) that illuminates deep surgical cavities from within for hospitals and surgical teams performing minimally-invasive procedures.
• ENLYT® ENLYT® is a portable flexible endoscope system designed for screening and imaging applications, particularly nasopharyngoscopy, enabling early screening and imaging from a global health perspective for hospitals and healthcare providers.
• ERES™ ERES™ is a minimally-invasive endoscopic surgical robotic system that integrates seamlessly with existing conventional endoscopes, designed to enable advanced endoluminal and NOTES-based procedures for hospitals and surgical teams.

Quantifiable outcome

• Over 1,100 sample units sold to hospitals globally
• +2 more outcomes

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered core, flagship and minor.

• Singapore General HospitalcoreStrategic or Co-development PartnerMajor public hospital in Singapore serving as a clinical research partner for testing and validating Vivo Surgical's endoscopic and surgical lighting technologies in real clinical settings.
• National Cancer Centre SingaporecoreStrategic or Co-development PartnerSpecialized cancer center collaborating with Vivo Surgical on applications of surgical lighting and endoscopy technology for surgical oncology procedures.
• Johnson & Johnson Innovation JLABSflagshipStrategic or Co-development PartnerInnovation incubator partnership providing Vivo Surgical with access to JLABS ecosystem, resources, and potential commercial pathways within the Johnson & Johnson network.
• Duke UniversitycoreStrategic or Co-development PartnerAcademic medical center partnership involving research collaboration on medical device development and clinical applications of Vivo Surgical's technology platforms.
• Mount Sinai Innovation PartnerscoreGTM or Marketing PartnerTechnology transfer and commercialization partnership with Mount Sinai health system in the US, facilitating market entry and clinical validation in the American healthcare market.
• SingHealthcoreStrategic or Co-development PartnerSingapore's largest public healthcare cluster providing clinical research partnerships across multiple hospitals for technology validation and clinical studies.
• Duke Global Health InstituteminorStrategic or Co-development PartnerAcademic partnership through Duke University's global health research institute for international health applications and research collaborations.
• National ENT Hospital VietnamminorChannel Partner/ Reseller/ DistributorDistribution and clinical partnership in Vietnam for ENT applications of ENLYT® flexible endoscopy technology in the Southeast Asian market.
• National Institutes of Health (NIH)minorStrategic or Co-development PartnerUS government research agency partnership for potential research collaborations on medical device development and clinical applications.
• Enterprise SingaporeflagshipGTM or Marketing PartnerGovernment agency partnership supporting Singapore-based companies with international expansion, market access support, and recognition programs.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Asensus Surgical: Developer of the Senhance surgical robotic system with a focus on digital laparoscopy. Comparable to ERES as an early-to-mid-stage surgical robotics peer seeking hospital adoption outside Intuitive Surgical's footprint.
• CMR Surgical: Developer of the Versius surgical robotic system for minimally-invasive laparoscopic surgery. Comparable to ERES as a growth-stage surgical robotics competitor targeting similar hospital segments.
• Noah Medical: Developer of the Ion fully-shape-sensing robotic-assisted bronchoscopy platform. Comparable to ERES as an emerging robotic endoscopy player targeting advanced minimally-invasive endoluminal procedures.

Broad incumbents

• Intuitive Surgical: Global leader in surgical robotics with the da Vinci platform. Directly relevant as the dominant incumbent ERES must compete against in minimally-invasive robotic surgery, and a benchmark for surgical robotics commercialization.
• Olympus: Global leader in flexible endoscopy systems. Comparable to ENLYT as the dominant incumbent in flexible endoscopic imaging used in nasopharyngoscopy and GI procedures.
• Boston Scientific: Diversified medtech incumbent with significant endoscopy and surgical portfolios. Relevant as both a peer in endoscopic devices (ENLYT) and as the prior employer of Vivo Surgical advisory board member Mr Yasushi Takigawa.
• Medtronic: Global medtech incumbent operating across surgical instruments, endoscopy and robotic-assisted surgery (Hugo platform). Comparable as a broad incumbent that competes with both ERES and ENLYT.
• Stryker: Large diversified medical device incumbent with surgical lighting, instrumentation and endoscopy portfolios (including the acquired Invuity illumination franchise). Comparable as a broad incumbent that competes across KLARO's and ENLYT's categories.

Direct peers

• Ambu: Pioneer of single-use endoscopes, particularly in bronchoscopy and ENT. Directly comparable to ENLYT's single-use portable endoscope positioning and global health screening thesis.
• Karl Storz: Specialist manufacturer of endoscopes and minimally-invasive surgical visualization systems. Highly comparable to ENLYT as a focused endoscopy player with overlapping clinical use cases in ENT and GI procedures.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCDRdF4M2W65MicwTpNpj00Q/featured
• LinkedInlinkedin.com/company/vivo-surgical-pte-ltd

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vivo Surgical